DJIA 16,805.41 127.51 0.76%
NASDAQ 4,483.72 30.92 0.69%
S&P 500 1,964.58 13.76 0.71%
market minute promo

Verastem, Inc. (NASDAQ: VSTM)

9.59 0.63 (7.03%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

VSTM $9.59 7.03%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $8.97
Previous Close $8.96
Daily Range $8.97 - $9.92
52-Week Range $7.10 - $16.60
Market Cap $247.8M
P/E Ratio -4.72
Dividend (Yield) $0.00 (0.0%)
Volume 401,691
Average Daily Volume 198,730
Current FY EPS -$2.03

Sector

Healthcare

Industry

Drugs

Verastem, Inc. (VSTM) Description

Verastem Inc is a biopharmaceutical company focused on discovering and developing proprietary small molecule drugs targeting cancer stem cells along with proprietary companion diagnostics. Website: http://www.verastem.com/

News & Commentary

Verastem Inc.'s Upcoming Catalysts

Verastem might have to compete with GlaxoSmithKine, but Eli Lilly won't be a problem since it's targeting patients that have already taken Lilly's drug.

Verastem (VSTM) Crumbles: Stock Falls by 6.1% - Tale of the Tape

Verastem (VSTM) in Focus: Stock Adds 14% in Session - Tale of the Tape

Why Verastem Inc Shares Took Off Today

Is this meaningful? Or just another movement?

Healthcare Stocks Mixed; Verastem Surges After Publishing Supportive Data for Its Anti-Cancer Therap

Healthcare Stocks Mixed; Verastem Surges After Publishing Supportive Data for Its Anti-Cancer Therapy

Sector Update: Healthcare

UPDATE: Deutsche Bank Initiates Coverage On Verastem On Multiple Positive Factors

Oversold Conditions For Verastem (VSTM)

Verastem: Cancer May Have Met Its Match

Verastem Becomes Oversold (VSTM)

See More VSTM News...